The sensor system will be developed for the early diagnosis of adult diseases based on biomarkers in urine. Credit: Tatiana from Pixabay.

Dx&Vx has received a government project in South Korea for the development of a diagnostic sensor kit for adult diseases.

This national project, named Korea-led K-Sensor Technology Development for Market Leadership, is backed by the Ministry of Trade, Industry and Energy and is managed by the Korea Evaluation Institute of Industrial Technology.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Dx&Vx will lead the development as part of the three-year project, which was allocated a budget of up to $3.6m, including $2.8m from the government.

The project will be supported by the Korea Electronics Technology Institute, the Department of Electrical and Electronics Engineering at Korea University and the Department of Urology at Hanyang University College of Medicine.

COREE Group will be involved in the final commercialisation of the project.

A Dx&Vx official said: “Starting with the diagnostic development business that combines biotechnology and semiconductors, we will expand the development of additional modules using AI and IoT technologies, data analysis algorithms and technologies for early diagnosis.”

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

The project will mainly target the development of a sensor system for the early diagnosis of adult diseases based on biomarkers in urine.

The system is expected to help detect biomarkers in urine for full-time monitoring and early diagnosis of several adult diseases, including prostate cancer and diabetes.

Furthermore, the project will focus on the development of an in vitro point-of-care device that can measure different biomarkers using microelectromechanical system technology and optical technology.

The device will also leverage semiconductor technology for signal processing and artificial intelligence analysis technology.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
SC MEDICA’s minimally invasive, radiation free spinal facet fixation system, FFX® is transforming spinal pain management and improving outcomes for surgeons and patients alike. Learn how SC MEDICA’s award-winning technology is redefining standards in facet joint pain treatment.

Discover the Impact